EXAMINE THIS REPORT ON MBL77

Not all patients with CLL demand therapy. Despite all current advancements, the iwCLL nevertheless endorses watchful observation for individuals with asymptomatic condition.86 This suggestion is based on a minimum of two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).10